We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
4 own
5 watching
Current Price
$11.09
$0.06
(0.54%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
468.8M
52-Week High
13.66
52-Week Low
6.87
Average Volume
0.11M
Dividend Yield
--
P/E Ratio
--
Market Capitalization468.8M
52-Week High13.66
52-Week Low6.87
Average Volume0.11M
Dividend Yield--
P/E Ratio--
What does the Stockal+Disclaimer.pdf do?
AxoGen, Inc. provides surgical solutions for peripheral nerve injuries. The company's surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect injured peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that is used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed. In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Zolmax
1month ago
StockNews.com upgraded shares of AxoGen (NASDAQ:AXGN Get Rating) from a hold rating to a buy rating in a report issued on Thursday morning. AxoGen Trading Down 3.7 % AXGN opened at $11.32 on Thursday. AxoGen has a 52 week low of $6.87 and a 52 week high of $16.02. The business has a fifty [] ...
Zolmax
2 months ago
Exchange Traded Concepts LLC decreased its holdings in AxoGen, Inc. (NASDAQ:AXGN Get Rating) by 61.6% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 94,212 shares of the medical equipment providers stock after selling 151,117 shares during...
Ticker Report
3 months ago
AxoGen, Inc. (NASDAQ:AXGN Get Rating) Director Gregory Gene Freitag sold 24,000 shares of the businesss stock in a transaction that occurred on Thursday, August 4th. The shares were sold at an average price of $10.64, for a total transaction of $255,360.00. Following the completion of...
Globe Newswire
4 months ago
ALACHUA. Fla. and TAMPA, Fla, July 29, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, chairman, CEO, and president, will present at Canaccord Genuity's ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$11.09
$0.06
(0.54%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00